Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men
Table 2
Multivariate regression models.
Primary predictor
Total BMD
Total BMC
Std Reg Coeff# (95% CI)
-value
Std Reg Coeff# (95% CI)
-value
All subjects ()
โLeptin (ln)*
0.08 (โ0.11, 0.27)
0.38
0.06 (โ0.13, +0.25)
0.54
โLeptin (ln)**
โ0.11 (โ0.34, +0.12)
0.35
โ0.19 (โ0.38, +0.01)
0.07
Subjects with lipoatrophy ()
โLeptin (ln)*
โ0.68 (โ1.22, โ0.14)
0.02
โ0.74 (โ1.27, โ0.21)
<0.01
โLeptin (ln)&
โ0.92 (โ1.62, โ0.22)
0.01
โ0.80 (โ1.32, โ0.29)
<0.01
#Standardized regression coefficient.
*Adjusted for age and race.
**Adjusted for age, race, truncal fat, appendicular fat, and lean body mass.
&Adjusted for age, race, lean body mass, truncal fat, and total fat.